JULIE LLOYD: Open Payments
NPI 1194374959 · DOYLESTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 19 payments from 7 companies in 2025. Trend: 2023 $491 · 2024 $678 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $250 |
| Grifols USA, LLC | 2 | $39 |
| Verona Pharma, Inc. | 1 | $29 |
| Amgen Inc. | 1 | $24 |
| Insmed, Inc. | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: NUCALA, Prolastin-C Liquid, Ohtuvayre, TAVNEOS, Arikayce, PURIFIED CORTROPHIN GEL, DUPIXENT, TRELEGY ELLIPTA.
Industry payments across OH — which companies pay providers there.
